Experts discuss the implications of the FDA’s potential pathway to expand testosterone replacement therapy labeling for low libido in men with idiopathic hypogonadism. In their announcement, the FDA ...

Texas billionaire Robert Rowling is making a quiet play on one of the country’s most storied resorts, acquiring more than $200 million in debt tied to the Greenbrier and other properties linked to ...

CHARLESTON, W.Va. (WOWK) — A new company has acquired the loans for West Virginia’s crown jewel resort. In a statement late Wednesday night, Greenbrier President Dr. Jill Justice told 13 News: “We can ...

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. If you’ve been feeling a little low in more than one aspect of ...

The neuroscientist, health guru, and controversial podcaster Andrew Huberman just revealed something that has his fans fuming — but also not all that surprised. During a nearly three-hour interview ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

View post: Nutritionist Shares the $3.29 Trader Joe's Snack That Helps Her Hit Her Protein and Fiber Goals At the Same Time If you pay even a little attention to the health and wellness space, you’ve ...

Trio-Tech International engages in the provision of third-party semiconductor testing and burn-in services. It operates through the following segments: Semiconductor Back-End Solutions (SBS) and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A Food and Drug Administration panel on Wednesday advocated for regulatory changes that would make testosterone medications more widely accessible, including removing their classification as ...

Experts recommend removing unsupported prostate cancer warnings from TRT labels and aligning indications with professional guidelines. Testosterone's Schedule III classification creates barriers to ...